Bryan T Baldasare insider trades

Open-market stock purchases and sales by Bryan T Baldasare, Director at InMed Pharmaceuticals Inc, from SEC Form 4 filings since Sep 16, 2019.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • INM InMed Pharmaceuticals Inc: other filings, last Dec 20, 2024
  • VIVO Meridian Bioscience Inc: 1 buy, 2 sales, last Dec 15, 2021

Get free alerts when Bryan T Baldasare files a new trade →